SCHEMBL10133744

SCHEMBL10133744

C=C(C)C1Cc2c(ccc(C3=NOC4COc5cc(OC)c(OC)cc5C34)c2OCC(C)=O)O1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 9/20 0.59
▸ MAPT P10636 8/20 0.59
▸ SMN1; SMN2 Q16637 6/20 0.59
▸ ALDH1A1 P00352 4/20 0.59
▸ CYP2C19 P33261 4/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ LMNA P02545 4/20 0.59
▸ TP53 P04637 4/20 0.59
▸ TSHR P16473 3/20 0.59
▸ CYP2C9 P11712 3/20 0.59
▸ MAPK1 P28482 3/20 0.59
▸ MT-ND4 P03905 3/20 0.59
▸ TDP1 Q9NUW8 3/20 0.59
▸ USP2 O75604 3/20 0.59
▸ NPC1 O15118 2/20 0.59
▸ RAB9A P51151 2/20 0.59
▸ CYP1A2 P05177 2/20 0.59
▸ HPGD P15428 2/20 0.59
▸ GMNN O75496 1/20 0.59
▸ ABCB11 O95342 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2631491 0.95 CYP3A4 (0.58) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL19828217 0.91 CYP3A4 (0.54) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248245 0.89 CYP3A4 (0.54) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248243 0.89 CYP3A4 (0.52) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13056524 0.88 CYP3A4 (0.51) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL15744050 0.88 CYP3A4 (0.53) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248253 0.88 CYP3A4 (0.51) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248250 0.87 CYP3A4 (0.50) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248252 0.86 CYP3A4 (0.49) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248254 0.85 CYP3A4 (0.48) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003476-A2 HAPTEN CONJUGATES FOR TARGET DETECTION VENTANA MEDICAL SYSTEMS, INC. (US) 2012-01-05 — — WO disclosed
Send feedback